Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

4.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De novo design of miniproteins targeting GPCRs.

Nature·2026
Same author

Advancing AAV technology-From promise to product.

Molecular therapy. Advances·2026
Same author

<i>In vivo</i> HSC gene therapy enables sustained eCD4-Ig expression for SIV prevention.

Molecular therapy. Advances·2026
Same author

Kinetics of the O<sub>2</sub> Reactions with CH<sub>3</sub>OCO and CH<sub>2</sub>OCHO Formed from Methyl Formate.

The journal of physical chemistry. A·2026
Same author

In vitro and in vivo base editing of CCR5 in hematopoietic stem cells confers HIV-1 resistance.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Junction opener enables CAR T cell treatment of solid tumors.

Scientific reports·2026

Related Experiment Video

Updated: Feb 23, 2026

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

12.5K

In Vivo Hematopoietic Stem Cell Transduction.

Maximilian Richter1, Daniel Stone2, Carol Miao3

  • 1Division of Medical Genetics, University of Washington, 1705 NE Pacific Street, Seattle, WA 98195, USA.

Hematology/Oncology Clinics of North America
|September 13, 2017
PubMed
Summary

In vivo hematopoietic stem cell (HSC) gene therapy offers a less complex alternative to traditional ex vivo methods. This approach modifies HSCs directly within the body, reducing patient risk and improving therapeutic potential.

Keywords:
IntraossealIntravenousMobilizationViral vectors

More Related Videos

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

973
Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
08:14

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

Published on: December 3, 2015

7.9K

Related Experiment Videos

Last Updated: Feb 23, 2026

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

12.5K
In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

973
Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
08:14

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

Published on: December 3, 2015

7.9K

Area of Science:

  • Hematology
  • Gene Therapy
  • Molecular Biology

Background:

  • Current ex vivo hematopoietic stem cell (HSC) gene therapy requires complex procedures and carries risks for patients.
  • In vivo gene therapy presents a promising alternative by directly modifying HSCs within the body.

Purpose of the Study:

  • To explore and exemplify in vivo hematopoietic stem cell (HSC) gene therapy strategies.
  • To discuss the advantages and disadvantages of in vivo HSC gene therapy approaches.

Main Methods:

  • Direct modification of HSCs in bone marrow via intraosseous injection of gene delivery vectors.
  • Mobilization of HSCs into peripheral blood, followed by intravenous vector injection and subsequent bone marrow re-engraftment.

Main Results:

  • In vivo approaches offer potential for simplified and safer HSC gene modification.
  • Examples of in vivo strategies demonstrate feasibility and varying outcomes.

Conclusions:

  • In vivo HSC gene therapy holds significant promise for simplifying treatment protocols and enhancing patient safety.
  • Further research into in vivo methods is warranted to optimize efficacy and minimize risks.